Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;99:2942-2950

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakajima, T.
Right arrow Articles by Okuda, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakajima, T.
Right arrow Articles by Okuda, Y.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*VERAPAMIL HYDROCHLORIDE
Related Collections
Right arrow Calcium cycling/excitation-contraction coupling
Right arrow Heart failure - basic studies

(Circulation. 1999;99:2942-2950.)
© 1999 American Heart Association, Inc.


Basic Science Reports

Troglitazone Inhibits Voltage-Dependent Calcium Currents in Guinea Pig Cardiac Myocytes

Toshiaki Nakajima, MD; Kuniaki Iwasawa, MD; Hitoshi Oonuma, MD; Hiroyuki Imuta, PhD; Hisanori Hazama, MD; Michiko Asano, MD; Toshihiro Morita, MD; Fumitaka Nakamura, MD; Jun-ichi Suzuki, MD; Seiji Suzuki, MD; Yasushi Kawakami, MD; Masao Omata, MD; Yukichi Okuda, MD

From the Second Department of Internal Medicine, Faculty of Medicine, University of Tokyo (T.N., K.I., H.O., H.I., H.H., M.A., T.M., F.N., J.S., M.O.), and the Department of Internal Medicine, Institute of Clinical Medicine, University of Tsukuba (S.S., Y.K., Y.O.), Ibaraki, Japan.

Correspondence to T. Nakajima, MD, Second Department of Internal Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.

Background—It has been suggested that intracellular Ca2+ overload in cardiac myocytes leads to the development of diabetic cardiomyopathy. Troglitazone, an insulin-sensitizing agent, is a promising therapeutic agent for diabetes and has been shown to prevent diabetes-induced myocardial changes. To elucidate the underlying mechanism of troglitazone action on cardiac myocytes, the effects of troglitazone on voltage-dependent Ca2+ currents were examined and compared with classic Ca2+ antagonists (verapamil and nifedipine).

Methods and Results—Whole-cell voltage-clamp techniques were applied in single guinea pig atrial myocytes. Under control conditions with CsCl internal solution, the voltage-dependent Ca2+ currents consisted of both T-type (ICa,T) and L-type (ICa,L) Ca2+ currents. Troglitazone effectively reduced the amplitude of ICa,L in a concentration-dependent manner. Troglitazone also suppressed ICa,T, but the effect of troglitazone on ICa,T was less potent than that on ICa,L. The current-voltage relationships for ICa,L and the reversal potential for ICa,L were not altered by troglitazone. The half-maximal inhibitory concentration of troglitazone on ICa,L measured at a holding potential of -40 mV was 6.3 µmol/L, and 30 µmol/L troglitazone almost completely inhibited ICa,L. Troglitazone 10 µmol/L did not affect the time courses for inactivation of ICa,L and inhibited ICa,L mainly in a use-independent fashion, without shifting the voltage-dependency of inactivation. This effect was different from those of verapamil and nifedipine. Troglitazone also reduced isoproterenol- or cAMP-enhanced ICa,L.

Conclusions—These results demonstrate that troglitazone inhibits voltage-dependent Ca2+ currents (T-type and L-type) and then antagonizes the effects of isoproterenol in cardiac myocytes, thus possibly playing a role in preventing diabetes-induced intracellular Ca2+ overload and subsequent myocardial changes.


Key Words: troglitazone • myocytes • calcium • isoproterenol • diabetes • cardiomyopathy




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T.-M. Lee and T.-F. Chou
Troglitazone administration limits infarct size by reduced phosphorylation of canine myocardial connexin43 proteins
Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1650 - H1659.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Terasawa, T. Nakajima, H. Iida, K. Iwasawa, H. Oonuma, T. Jo, T. Morita, F. Nakamura, Y. Fujimori, T. Toyo-oka, et al.
Nonselective Cation Currents Regulate Membrane Potential of Rabbit Coronary Arterial Cell: Modulation by Lysophosphatidylcholine
Circulation, December 10, 2002; 106(24): 3111 - 3119.
[Abstract] [Full Text] [PDF]


Home page
Adv. Physiol. Educ.Home page
S. Yoshida
SIMPLE TECHNIQUES SUITABLE FOR STUDENT USE TO RECORD ACTION POTENTIALS FROM THE FROG HEART
Advan Physiol Educ, September 1, 2001; 25(3): 176 - 186.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
Li Yao, K. Mizushige, T. Noma, K. Murakami, K. Ohmori, and H. Matsuo
Improvement of Left Ventricular Diastolic Dynamics in Prediabetic Stage of A Type II Diabetic Rat Model After Troglitazone Treatment
Angiology, January 1, 2001; 52(1): 53 - 57.
[Abstract] [PDF]